To hear about similar clinical trials, please enter your email below

Trial Title: Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

NCT ID: NCT06357533

Condition: Non-Small Cell Lung Cancer

Conditions: Official terms:
Carcinoma, Non-Small-Cell Lung
Pembrolizumab

Conditions: Keywords:
NSCLC
Non-Small Cell Lung Cancer
Datopotamab Deruxtecan
Rilvegostomig
Pembrolizumab
Non-squamous
PD-L1 expression >=50%
Locally-advanced NSCLC
Metastatic NSCLC

Study type: Interventional

Study phase: Phase 3

Overall status: Recruiting

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Intervention model description: Parallel Assignment

Primary purpose: Treatment

Masking: Single (Outcomes Assessor)

Masking description: Open-label, sponsor-blinded

Intervention:

Intervention type: Drug
Intervention name: Datopotamab Deruxtecan
Description: Datopotamab Deruxtecan IV (intravenous)
Arm group label: Arm 1: Dato-DXd in Combination With Rilvegostomig

Other name: Dato-DXd

Intervention type: Drug
Intervention name: Rilvegostomig
Description: Rilvegostomig IV (intravenous)
Arm group label: Arm 1: Dato-DXd in Combination With Rilvegostomig
Arm group label: Arm 2: Rilvegostomig Monotherapy

Other name: AZD2936

Intervention type: Drug
Intervention name: Pembrolizumab
Description: Pembrolizumab IV (intravenous)
Arm group label: Arm 3: Pembrolizumab Monotherapy

Other name: KEYTRUDA

Summary: The purpose of this study is to evaluate efficacy and safety of Dato-DXd in combination with rilvegostomig or rilvegostomig monotherapy compared with pembrolizumab monotherapy as a first line therapy in participants with locally advanced or metastatic non-squamous NSCLC with high PD-L1 expression (TC ≥ 50%) and without actionable genomic alterations.

Detailed description: This is a Phase III, randomized, open-label, Global Study of Datopotamab Deruxtecan (Dato-DXd) in Combination With Rilvegostomig or Rilvegostomig monotherapy versus Pembrolizumab monotherapy for the first-line treatment of participants with locally-advanced or metastatic non-squamous NSCLC with high PD-L1 expression (TC ≥ 50%) and without actionable genomic alterations.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Histologically or cytologically documented non-squamous NSCLC. - Stage IIIB or IIIC or Stage IV metastatic NSCLC (according to Edition 8 of the AJCC staging manual) not amenable to curative surgery or definitive chemoradiation. - Absence of sensitising EGFR mutations, and ALK and ROS1 rearrangements, and absence of documented local test result for any other known genomic alteration for which there are locally approved targeted first-line therapies. - Must provide tumor sample to determine PD-L1 status, TROP2 status and other biomarkers. - Known tumour PD-L1 expression status defined as TC ≥ 50% - At least one lesion, not previously irradiated that qualifies as a RECIST 1.1 target lesion at baseline - ECOG performance status of 0 or 1 - Adequate bone marrow reserve and organ function within 7 days before the first dose of study intervention Exclusion Criteria: - Prior systemic therapy for advanced/metastatic NSCLC. - Squamous cell histology, or predominantly squamous cell histology NSCLC; mixed small cell lung cancer; NSCLC histology, sarcomatoid variant. - History of another primary malignancy within 3 years - Active or prior documented autoimmune or inflammatory disorders (with exceptions) - Any evidence of severe or uncontrolled systemic diseases, including, but not limited to active bleeding diseases, active infection, active ILD/pneumonitis, cardiac disease. - Has clinically significant third-space fluid retention (for example pleural effusion) and is not amenable for repeated drainage. - History of non-infectious ILD/pneumonitis that required steroids, has current ILD/pneumonitis, or has suspected ILD/pneumonitis that cannot be ruled out by imaging at screening - Has severe pulmonary function compromise resulting from intercurrent pulmonary illnesses - Spinal cord compression, or brain metastases unless participant treated and no longer symptomatic, radiologically stable, and who require no treatment with corticosteroids or anticonvulsants. - History of leptomeningeal carcinomatosis - Known clinically significant corneal disease - Active infection with TB, HBV, HCV, Hepatitis A, or known HIV infection that is not well controlled - History of active primary immunodeficiency

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Research Site

Address:
City: Tucson
Zip: 85719
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Fayetteville
Zip: 72703
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Burbank
Zip: 91505
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Brandon
Zip: 33511
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Orlando
Zip: 32827
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Atlanta
Zip: 30322
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Boston
Zip: 02114
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Grand Rapids
Zip: 49503
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Hattiesburg
Zip: 39401
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Omaha
Zip: 68130
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Stony Brook
Zip: 11794
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Greenville
Zip: 27834
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Columbus
Zip: 43210
Country: United States

Status: Withdrawn

Facility:
Name: Research Site

Address:
City: Greenville
Zip: 29607
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Chattanooga
Zip: 37404
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Houston
Zip: 77090
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Kingwood
Zip: 77339
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Fort Belvoir
Zip: 22060
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Leesburg
Zip: 20176
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Tacoma
Zip: 98405
Country: United States

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Clayton
Zip: 3168
Country: Australia

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Melbourne
Zip: 3000
Country: Australia

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: South Brisbane
Zip: QL 4101
Country: Australia

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Innsbruck
Zip: 6020
Country: Austria

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Krems
Zip: 3500
Country: Austria

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Linz
Zip: 4020
Country: Austria

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Rankweil
Zip: 6830
Country: Austria

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Wels
Zip: 4600
Country: Austria

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Wien
Zip: 1140
Country: Austria

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Wien
Zip: 1210
Country: Austria

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Anderlecht
Zip: 1070
Country: Belgium

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Hasselt
Zip: 3500
Country: Belgium

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: La Louvière
Zip: 7100
Country: Belgium

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Barretos
Zip: 14784-400
Country: Brazil

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Curitiba
Zip: 80730-150
Country: Brazil

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Florianópolis
Zip: 88034-000
Country: Brazil

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Ipatinga
Zip: 35162-189
Country: Brazil

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Natal
Zip: 59075-740
Country: Brazil

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Porto Alegre
Zip: 91350-200
Country: Brazil

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Rio de Janeiro
Zip: 22211-230
Country: Brazil

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Santa Maria
Zip: 97015-450
Country: Brazil

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: São Paulo
Zip: 01221-020
Country: Brazil

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Taubaté
Zip: 12030-200
Country: Brazil

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Vancouver
Zip: VSZ 4E6
Country: Canada

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Winnipeg
Zip: R3E 0V9
Country: Canada

Status: Withdrawn

Facility:
Name: Research Site

Address:
City: London
Zip: N6A 4L6
Country: Canada

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Newmarket
Zip: L3Y 2P9
Country: Canada

Status: Withdrawn

Facility:
Name: Research Site

Address:
City: Oshawa
Zip: L1G 2B9
Country: Canada

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Toronto
Zip: M4N 3M5
Country: Canada

Status: Withdrawn

Facility:
Name: Research Site

Address:
City: Lévis
Zip: G6V 0B8
Country: Canada

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Montreal
Zip: H3T 1E2
Country: Canada

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Montreal
Zip: H4J 1C5
Country: Canada

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Rimouski
Zip: G5L 5T1
Country: Canada

Status: Recruiting

Facility:
Name: Research Site

Address:
City: Trois-Rivieres
Zip: G8Z 3R9
Country: Canada

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Chicoutimi
Zip: G7H 5H6
Country: Canada

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Gauting
Zip: 82131
Country: Germany

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Budapest
Zip: 1121
Country: Hungary

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Gyula
Zip: 5700
Country: Hungary

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Győr
Zip: 9024
Country: Hungary

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Kecskemét
Zip: 6000
Country: Hungary

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Salgótarján
Zip: 3100
Country: Hungary

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Szekszárd
Zip: 7100
Country: Hungary

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Székesfehérvár
Zip: 8000
Country: Hungary

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Törökbálint
Zip: 2045
Country: Hungary

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Dwarka
Zip: 110075
Country: India

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Jaipur
Zip: 302004
Country: India

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Kolkata
Zip: 700099
Country: India

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Marg Jaipur
Zip: 302004
Country: India

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Nagpur
Zip: 440001
Country: India

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Nashik
Zip: 422011
Country: India

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: New Delhi
Zip: 110085
Country: India

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: New Delhi
Zip: 11029
Country: India

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Thiruvananthapuram
Zip: 695011
Country: India

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Bergamo
Zip: 24125
Country: Italy

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Genoa
Zip: 16132
Country: Italy

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Milano
Zip: 20141
Country: Italy

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Milano
Zip: 20162
Country: Italy

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Monza
Zip: 20052
Country: Italy

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Padova
Zip: 35128
Country: Italy

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Pavia
Zip: 27100
Country: Italy

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Ravenna
Zip: 48100
Country: Italy

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Roma
Zip: 00128
Country: Italy

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Rozzano
Zip: 20089
Country: Italy

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Hidaka-shi
Zip: 350-1298
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Kawasaki-shi
Zip: 216-8511
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Nagoya-shi
Zip: 460-0001
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Okayama
Zip: 700-8558
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Sagamihara-shi
Zip: 252-0375
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Sapporo-shi
Zip: 003-0804
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Takaoka-shi
Zip: 933-8555
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Takatsuki-shi
Zip: 569-8686
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Tokushima-shi
Zip: 770-8503
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Tokyo
Zip: 104-0045
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Utsunomiya-shi
Zip: 320-0834
Country: Japan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Changwon
Zip: 51353
Country: Korea, Republic of

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Incheon
Zip: 21565
Country: Korea, Republic of

Status: Recruiting

Facility:
Name: Research Site

Address:
City: Seongnam-si
Zip: 13496
Country: Korea, Republic of

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Seoul
Zip: 03080
Country: Korea, Republic of

Status: Recruiting

Facility:
Name: Research Site

Address:
City: Seoul
Zip: 03722
Country: Korea, Republic of

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Suwon-si
Zip: 16499
Country: Korea, Republic of

Status: Recruiting

Facility:
Name: Research Site

Address:
City: Suwon
Zip: 16247
Country: Korea, Republic of

Status: Recruiting

Facility:
Name: Research Site

Address:
City: Olsztyn
Zip: 10-357
Country: Poland

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Poznań
Zip: 60-569
Country: Poland

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Warszawa
Zip: 01-138
Country: Poland

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Alicante
Zip: 03010
Country: Spain

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Barcelona
Zip: 08003
Country: Spain

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Barcelona
Zip: 08036
Country: Spain

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Jerez de la Frontera
Zip: 11407
Country: Spain

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Reus,Tarragona
Zip: 43204
Country: Spain

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Salamanca
Zip: 37007
Country: Spain

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Kaohsiung
Zip: 80756
Country: Taiwan

Status: Recruiting

Facility:
Name: Research Site

Address:
City: New Taipei
Zip: 220
Country: Taiwan

Status: Recruiting

Facility:
Name: Research Site

Address:
City: Taichung
Zip: 40447
Country: Taiwan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Tainan
Zip: 704
Country: Taiwan

Status: Recruiting

Facility:
Name: Research Site

Address:
City: Taipei
Zip: 10002
Country: Taiwan

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Taipei
Zip: 112
Country: Taiwan

Status: Recruiting

Facility:
Name: Research Site

Address:
City: Taipei
Zip: TAIWAN
Country: Taiwan

Status: Recruiting

Facility:
Name: Research Site

Address:
City: Taoyuan
Zip: 333
Country: Taiwan

Status: Recruiting

Facility:
Name: Research Site

Address:
City: Adapazarı
Zip: 54100
Country: Turkey

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Ankara
Zip: 06560
Country: Turkey

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Ankara
Zip: 6200
Country: Turkey

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Antalya
Zip: 07070
Country: Turkey

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Diyarbakir
Zip: 21280
Country: Turkey

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Istanbul
Zip: 34030
Country: Turkey

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Istanbul
Zip: 34890
Country: Turkey

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Cheltenham
Zip: GL53 7AN
Country: United Kingdom

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Inverness
Zip: IV2 3UJ
Country: United Kingdom

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: London
Zip: SE1 9RT
Country: United Kingdom

Status: Withdrawn

Facility:
Name: Research Site

Address:
City: London
Zip: SW10 9NH
Country: United Kingdom

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: London
Zip: SW17 0QT
Country: United Kingdom

Status: Not yet recruiting

Facility:
Name: Research Site

Address:
City: Truro
Zip: TR1 3LJ
Country: United Kingdom

Status: Not yet recruiting

Start date: April 11, 2024

Completion date: May 24, 2030

Lead sponsor:
Agency: AstraZeneca
Agency class: Industry

Collaborator:
Agency: Daiichi Sankyo
Agency class: Industry

Source: AstraZeneca

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT06357533

Login to your account

Did you forget your password?